180 Wealth Advisors LLC Boosts Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

180 Wealth Advisors LLC grew its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,238 shares of the exchange traded fund’s stock after acquiring an additional 373 shares during the quarter. 180 Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $382,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund increased its position in SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $141,284,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of SPDR S&P Biotech ETF by 1.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after acquiring an additional 18,202 shares during the period. Mirae Asset Securities USA Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares in the last quarter. Finally, Employees Retirement System of Texas boosted its position in SPDR S&P Biotech ETF by 40.8% during the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after purchasing an additional 174,857 shares during the period.

SPDR S&P Biotech ETF Trading Down 2.8 %

Shares of NYSEARCA XBI opened at $86.66 on Wednesday. The stock has a fifty day moving average price of $95.28 and a 200 day moving average price of $97.10. The company has a market cap of $6.61 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.